Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model. [electronic resource]
Producer: 20070626Description: 279-86 p. digitalISSN:- 1525-0016
- Animals
- Cell Line
- Cell Line, Tumor
- Cells, Cultured
- Chlorocebus aethiops
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Genetic Therapy -- methods
- Humans
- Immunoblotting
- In Situ Hybridization
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Neovascularization, Pathologic -- prevention & control
- Nerve Sheath Neoplasms -- genetics
- Oligonucleotide Array Sequence Analysis
- Oncolytic Virotherapy -- methods
- Protein Kinase Inhibitors -- pharmacology
- Quinazolines -- pharmacology
- Rabbits
- Reverse Transcriptase Polymerase Chain Reaction
- Simplexvirus -- genetics
- Vero Cells
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.